Boost for prostate treatment

I reported previously (Feb 2012) on Israel’s Medi-Tate and its non-invasive treatment for benign prostate enlargement.  Now Japan’s Olympus Corporation has invested $20 million in Medi-Tate and will market Medi-Tate’s iTind implant in several countries.,7340,L-3749102,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *